FIGO 2023 staging system predicts not only survival outcome but also recurrence pattern in corpus-confined endometrial cancer patients
Authors:
Open Access
- 8 January 2025
- journal article
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 64 (1) , 76-81
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centresEuropean Journal of Cancer, 2023
- FIGO staging of endometrial cancer: 2023International Journal of Gynecology & Obstetrics, 2023
- Recurrence and survival in endometrioid endometrial cancer - a population-based cohort studyGynecologic Oncology, 2022
- Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic SubtypeJAMA Oncology, 2022
- Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019Gynecologic Oncology, 2021
- Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendationsGynecologic Oncology, 2021
- Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapyGynecologic Oncology, 2019
- The nature of early-stage endometrial cancer recurrence—A national cohort studyEuropean Journal of Cancer, 2016
- Revised FIGO staging for carcinoma of the cervixInternational Journal of Gynecology & Obstetrics, 2009